BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21837785)

  • 1. Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men.
    Cattamanchi A; Saracino M; Selke S; Huang ML; Magaret A; Celum C; Corey L; Wald A; Casper C
    J Med Virol; 2011 Oct; 83(10):1696-703. PubMed ID: 21837785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generic acyclovir vs. famciclovir and valacyclovir.
    Grose C; Wiedeman J
    Pediatr Infect Dis J; 1997 Sep; 16(9):838-41. PubMed ID: 9306476
    [No Abstract]   [Full Text] [Related]  

  • 3. Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.
    Schiffer JT; Magaret A; Selke S; Corey L; Wald A
    J Antimicrob Chemother; 2011 Nov; 66(11):2593-600. PubMed ID: 21865349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
    Le Cleach L; Trinquart L; Do G; Maruani A; Lebrun-Vignes B; Ravaud P; Chosidow O
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009036. PubMed ID: 25086573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of new antiherpes agents: famciclovir and valacyclovir.
    Stein GE
    J Am Pharm Assoc (Wash); 1997; NS37(2):157-63. PubMed ID: 9069689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
    Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
    Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric uses of valacyclovir, penciclovir and famciclovir.
    Dekker CL; Prober CG
    Pediatr Infect Dis J; 2001 Nov; 20(11):1079-81. PubMed ID: 11734715
    [No Abstract]   [Full Text] [Related]  

  • 8. Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections.
    Wu JJ; Brentjens MH; Torres G; Yeung-Yue K; Lee P; Tyring SK
    J Cutan Med Surg; 2003; 7(5):372-81. PubMed ID: 14505192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs.
    Brown TJ; McCrary M; Tyring SK
    J Am Acad Dermatol; 2002 Oct; 47(4):581-99. PubMed ID: 12271305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of famciclovir and valaciclovir on pathogenesis of herpes simplex virus type 2 in a murine infection model.
    Thackray AM; Field HJ
    Antimicrob Agents Chemother; 1996 Apr; 40(4):846-51. PubMed ID: 8849238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
    Reusser P
    J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
    Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K
    Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.
    Nagot N; Ouédraogo A; Foulongne V; Konaté I; Weiss HA; Vergne L; Defer MC; Djagbaré D; Sanon A; Andonaba JB; Becquart P; Segondy M; Vallo R; Sawadogo A; Van de Perre P; Mayaud P;
    N Engl J Med; 2007 Feb; 356(8):790-9. PubMed ID: 17314338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency.
    Thackray AM; Field HJ
    J Infect Dis; 1996 Feb; 173(2):291-9. PubMed ID: 8568288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial.
    Perti T; Saracino M; Baeten JM; Johnston C; Diem K; Ocbamichael N; Huang ML; Selke S; Magaret A; Corey L; Wald A
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):201-8. PubMed ID: 23542637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral agents in women's health: pharmacotherapeutics of treating influenza and herpes.
    Burpo RH
    J Midwifery Womens Health; 2002; 47(3):182-189. PubMed ID: 12071383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy.
    Gantt S; Cattamanchi A; Krantz E; Magaret A; Selke S; Kuntz SR; Huang ML; Corey L; Wald A; Casper C
    J Clin Virol; 2014 Jun; 60(2):127-32. PubMed ID: 24698158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of famciclovir and valaciclovir in the treatment of viral keratitis.
    Gatchel S
    Clin Infect Dis; 1996 May; 22(5):886. PubMed ID: 8722973
    [No Abstract]   [Full Text] [Related]  

  • 20. Valacyclovir and famciclovir therapy in herpes zoster.
    Jubelt B
    Curr Neurol Neurosci Rep; 2002 Nov; 2(6):477-8. PubMed ID: 12359099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.